Turgut, F.; Somfai, G.M.; Tappeiner, C.; Hatz, K.; Mantel, I.; Ambresin, A.; Donati, G.; Guignard, V.; Nagyová, D.; Pfister, I.B.;
et al. Intravitreal Dexamethasone Implant in Anti-Vascular Endothelial Growth Factor Pretreated Diabetic Macular Edema—A Swiss Cohort Study. Pharmaceuticals 2024, 17, 1235.
https://doi.org/10.3390/ph17091235
AMA Style
Turgut F, Somfai GM, Tappeiner C, Hatz K, Mantel I, Ambresin A, Donati G, Guignard V, Nagyová D, Pfister IB,
et al. Intravitreal Dexamethasone Implant in Anti-Vascular Endothelial Growth Factor Pretreated Diabetic Macular Edema—A Swiss Cohort Study. Pharmaceuticals. 2024; 17(9):1235.
https://doi.org/10.3390/ph17091235
Chicago/Turabian Style
Turgut, Ferhat, Gábor M. Somfai, Christoph Tappeiner, Katja Hatz, Irmela Mantel, Aude Ambresin, Guy Donati, Viviane Guignard, Dana Nagyová, Isabel B. Pfister,
and et al. 2024. "Intravitreal Dexamethasone Implant in Anti-Vascular Endothelial Growth Factor Pretreated Diabetic Macular Edema—A Swiss Cohort Study" Pharmaceuticals 17, no. 9: 1235.
https://doi.org/10.3390/ph17091235
APA Style
Turgut, F., Somfai, G. M., Tappeiner, C., Hatz, K., Mantel, I., Ambresin, A., Donati, G., Guignard, V., Nagyová, D., Pfister, I. B., Schild, C., & Garweg, J. G.
(2024). Intravitreal Dexamethasone Implant in Anti-Vascular Endothelial Growth Factor Pretreated Diabetic Macular Edema—A Swiss Cohort Study. Pharmaceuticals, 17(9), 1235.
https://doi.org/10.3390/ph17091235
